Immuron announces research collaboration By Investing.com
Immuron Ltd (NASDAQ:IMRN), an Australian biopharmaceutical company with a market capitalization of $12 million, disclosed a new research collaboration with...
Immuron Ltd (NASDAQ:IMRN), an Australian biopharmaceutical company with a market capitalization of $12 million, disclosed a new research collaboration with...